The Complete Guide to Research Peptides

Peptides sit at the centre of modern life-science research. They are the short chains of amino acids that let cells talk to each other, that switch metabolic pathways on and off, and that a growing branch of biomedical research is learning to design deliberately. This guide is a careful, plain-language introduction to that world, written for researchers, students and science-literate readers who want a single reliable reference to return to.

The Peptide Research Hub is an independent educational library. We do not sell peptides and we do not give medical advice. What we do is explain the science, the quality standards, and the laboratory practices that separate credible research material from everything else. If you are new to the field, start here and work through in order. If you already know the fundamentals, use the table of contents to jump to quality testing, storage, or reconstitution.

By the end of this guide you will understand what peptides are at a molecular level, why they matter in current research, how their quality is measured with techniques such as high-performance liquid chromatography (HPLC), how they should be stored to remain stable, and how they are correctly reconstituted for laboratory use.

A peptide is a short chain of amino acids joined together by peptide bonds. Amino acids are the small organic molecules that living systems use as building blocks; twenty of them appear in the standard genetic code and are the ones most peptides are built from. When two amino acids join, a water molecule is released and a peptide bond forms between the carboxyl group of one and the amino group of the next. Chain enough of them together and you have a peptide.

The boundary between a peptide and a protein is a matter of convention rather than strict biology. Most sources describe a chain of roughly 50 amino acids or fewer as a peptide, and anything longer as a protein. Insulin, with 51 amino acids across two chains, is often described as a small protein, though many biologists still refer to it as a peptide hormone. The point is not the exact cut-off. The point is that peptides are short enough to be synthesised precisely in a laboratory, and long enough to fold into shapes with meaningful biological activity.

Naturally occurring peptides

The human body produces thousands of peptides. Some, like oxytocin and vasopressin, are hormones released by the pituitary. Others, like glucagon-like peptide-1 (GLP-1), are secreted by the gut in response to food. Antimicrobial peptides such as defensins are part of the immune system. Neuropeptides such as substance P modulate pain signalling. Peptides are, in short, one of biology's most versatile signalling languages.

Synthetic peptides

Researchers can now synthesise almost any peptide sequence to order. The dominant technique, solid-phase peptide synthesis (SPPS), was developed by Bruce Merrifield in 1963 and earned him the Nobel Prize in Chemistry in 1984. In SPPS, amino acids are added one by one to a growing chain anchored to a solid resin, with protecting groups managing which reactive site is active at each step. The result is a peptide of exactly the designed sequence, which can then be cleaved from the resin and purified.

One of the most common points of confusion for people entering peptide research is the distinction between amino acids, peptides, and proteins. All three are made of the same fundamental units, but they operate at very different scales and have very different properties.

Amino acids

Amino acids are the individual building blocks. Each has a central carbon atom bonded to an amino group, a carboxyl group, a hydrogen atom, and a distinctive side chain that determines its chemical behaviour. Some side chains are hydrophobic, some are charged, some carry sulphur atoms, and some are aromatic rings. Those side chains are why a chain of amino acids can fold into a shape that does something useful.

Peptides

Chain a handful of amino acids together and you have a peptide. Two amino acids make a dipeptide, three a tripeptide, and so on. Short peptides can be linear or, in many cases, cyclised head-to-tail or through side-chain bridges such as disulphide bonds. These modifications matter: they can dramatically increase stability, receptor selectivity, or resistance to enzymatic breakdown.

Proteins

Proteins are longer chains, often hundreds or thousands of amino acids, that fold into complex three-dimensional structures. Their behaviour depends not just on sequence but on that folding: an unfolded protein is usually a non-functional protein. Peptides, being shorter, are easier to characterise, synthesise, and modify, which is a large part of why they are so heavily used in research.

Most peptides do their work by binding to a specific receptor on the surface of a cell. Receptors are proteins that sit in the cell membrane with part of their structure sticking outside the cell and part reaching inside. When the right peptide arrives and locks into the receptor's binding site, the receptor changes shape. That shape change is a signal, and the inside of the cell responds.

Receptor binding as a lock and key

The traditional analogy is a lock and key: only a peptide with the right sequence and folding fits a given receptor. Modern structural biology has refined this picture. Binding is dynamic, receptors are flexible, and small changes in sequence can dramatically change how tightly a peptide binds and what downstream signal it triggers. This is why research peptides are often studied as families of closely related analogues rather than single molecules.

Downstream signalling

A receptor that has bound its peptide typically activates a cascade of intracellular events. Many peptide receptors are G protein-coupled receptors (GPCRs), which activate signalling proteins on the inside of the membrane. Others are enzyme-linked receptors that switch on catalytic activity directly. The end result is usually a change in gene expression, metabolism, ion transport, or cell behaviour.

Why peptides are attractive research targets

• They act on specific receptors, which often means fewer off-target effects.
• They can be designed and synthesised precisely to test structure-activity relationships.
• They break down into amino acids, which are the body's normal building blocks.
• Their short half-lives can be tuned by modification for research needs.

Peptide research has expanded dramatically over the past two decades. The reasons are practical as much as scientific. Peptides are specific, they are synthesisable, they are structurally tractable, and modern analytical tools can characterise them in extraordinary detail. All of that has turned peptides into one of the most productive corners of molecular research.

Understanding biology

Many of the body's core signalling systems run on peptides. Studying how a peptide binds its receptor, what its natural sequence looks like across species, and what happens when the sequence is changed teaches us about the underlying biology. This is fundamental work: understanding how life is regulated at the molecular level.

Developing new tools

Peptides make excellent research tools. Labelled peptides help scientists locate receptors in tissue samples. Antagonist peptides can be used to block a pathway and see what changes. Cyclic peptides can probe protein-protein interactions that smaller molecules cannot reach. The peptide is a scalpel, not a hammer.

Therapeutic exploration

More than a hundred peptide drugs have already been approved for medical use, from insulin analogues to GLP-1 receptor agonists, and hundreds more are in clinical development. The research peptides available to laboratories are the raw material for that exploratory work: they let researchers characterise mechanisms in cell and animal models long before anything reaches a clinical setting.

Research peptides are usually organised by their biological target or by the system they act on. The categories overlap, and many peptides could reasonably sit in more than one, but the following framework covers most of the field.

Metabolic peptides

These interact with pathways that regulate glucose, appetite, and energy balance. The best known group is the incretin family, including GLP-1 receptor agonists such as semaglutide and dual-receptor agonists such as tirzepatide. They are intensively studied because of their central role in metabolic biology.

Growth and repair peptides

Peptides in this group interact with growth hormone signalling, tissue repair, or collagen synthesis. Research examples include growth hormone secretagogues and peptides studied for their effects on wound healing and connective tissue.

Cognitive and neurological peptides

Neuropeptides modulate mood, memory, and neuroplasticity. Selank, semax, and related compounds are studied in this space, along with peptides that interact with opioid, oxytocin, and neurotrophin systems.

Immune and antimicrobial peptides

The body produces many peptides that are part of its innate immune system. Research in this area is expanding as antibiotic resistance drives interest in alternative antimicrobial strategies.

Structural and signalling peptides

A large residual category covers peptides used to probe specific receptor systems, from angiotensin analogues to melanocortin receptor ligands. These are typically research tools rather than therapeutic candidates.

Glucagon-like peptide-1 (GLP-1) is a hormone produced in the small intestine in response to food. It stimulates insulin release, suppresses glucagon, slows gastric emptying, and signals satiety to the brain. Endogenous GLP-1 has a half-life of only a couple of minutes, which is why so much research has focused on developing long-acting analogues that resist degradation.

The incretin system

GLP-1 belongs to the incretin family, alongside glucose-dependent insulinotropic polypeptide (GIP). Incretins are the reason an oral glucose load produces a larger insulin response than the same amount of glucose given intravenously. Understanding this system is central to the biology of type 2 diabetes and metabolic disease more broadly.

Modern GLP-1 analogues

Modern GLP-1 receptor agonists are engineered to resist the enzyme DPP-4, which normally clips native GLP-1 apart, and to bind albumin to prolong their circulating half-life. This is how compounds like semaglutide achieve once-weekly dosing in clinical use. Newer molecules like tirzepatide add activity at the GIP receptor, and further multi-agonists are in development.

What is being studied

• Metabolic effects on glucose control, body weight, and lipid handling.
• Cardiovascular and renal outcomes in animal and clinical studies.
• Neuroprotective and anti-inflammatory signalling in preclinical models.
• Structure-activity relationships that inform next-generation designs.

Peptide research spans a wide toolbox of laboratory methods. Understanding at a high level what these methods do, and what they can and cannot tell you, is a useful literacy for anyone reading peptide research.

Cell culture assays

The first port of call for characterising a new peptide is usually a cell-based assay. Cells expressing the relevant receptor are exposed to the peptide, and a downstream readout, such as cyclic AMP production or calcium flux, is measured. This produces a dose-response curve and quantifies potency and efficacy.

Binding assays

Binding assays measure how tightly a peptide sticks to its receptor, usually by competing it against a labelled reference ligand. Techniques include radioligand binding, fluorescence polarisation, and surface plasmon resonance.

Animal studies

When a peptide progresses beyond cell work, animal models are used to characterise its behaviour in a living system: pharmacokinetics, distribution, metabolism, and in vivo effects on physiology. These studies are highly regulated and are performed only in appropriately licensed facilities.

Analytical chemistry

Underpinning everything is analytical chemistry. Mass spectrometry confirms the molecular weight and sequence. HPLC measures purity. Circular dichroism and NMR probe secondary structure. Without this analytical backbone, no biological result is trustworthy: if you do not know exactly what is in your vial, you do not know what your assay is measuring.

Peptide quality is the single most important variable in peptide research, and it is the one that outsiders underestimate most often. Two vials labelled with the same sequence can behave very differently if one is 99% pure and the other is 92% pure, because that missing 7% is not empty space. It is other peptides, truncated sequences, oxidised variants, and manufacturing residues, all of which can be biologically active in their own right.

What "purity" actually means

Purity, in the context of a research peptide, usually refers to the percentage of the total peptide mass in the vial that corresponds to the intended sequence, as measured by HPLC. A purity of 98% means that 98% of the peptide content is the target compound and 2% is impurities. It does not mean 98% of the vial is peptide and 2% is water; other things such as trifluoroacetic acid counter-ions, residual solvents, and moisture are measured separately.

Where impurities come from

• Truncated sequences: peptide chains that lost an amino acid during synthesis.
• Deletion sequences: chains missing an internal amino acid.
• Oxidised variants: methionine or cysteine residues that reacted with oxygen.
• Deamidation products: asparagine or glutamine residues that hydrolysed.
• Aggregates: peptides that clumped together during synthesis or storage.

High-performance liquid chromatography is the workhorse technique for peptide purity analysis. The principle is simple even if the instrumentation is not: you push a dissolved sample through a column packed with a stationary phase, and the different components in the sample come out the other end at different times depending on how strongly they interact with the packing.

Reversed-phase HPLC

The dominant mode for peptides is reversed-phase HPLC, usually on a C18 column. The stationary phase is hydrophobic and the mobile phase is a gradient from water-rich to solvent-rich (typically water plus acetonitrile, with a small amount of trifluoroacetic acid as an ion-pairing agent). Hydrophobic peptides stick to the column longer and elute later. As each component leaves the column, a detector, usually UV at 214 nm or 220 nm, produces a peak on the chromatogram.

Reading a chromatogram

• The x-axis is time. The y-axis is detector response (absorbance).
• Each peak is a component in the sample.
• The area under each peak is proportional to its concentration.
• The main peak should dominate the chromatogram, with impurities as smaller peaks.
• Purity is reported as (main peak area / total peak area) × 100.

Coupling with mass spectrometry

On its own, HPLC tells you how many components are in a sample and in what ratios, but it does not tell you what those components are. Coupling HPLC to a mass spectrometer (HPLC-MS or LC-MS) gives each peak an accurate mass, which confirms that the main peak is the intended peptide and identifies impurities such as oxidised or truncated variants.

A certificate of analysis (CoA) is the paperwork that accompanies a batch of research peptide and documents the analytical tests performed on it. A credible CoA is specific to a batch, dated, and signed. A generic PDF that could apply to any batch is not a certificate of analysis.

What to look for

• Peptide name, sequence, molecular formula and molecular weight.
• Batch or lot number, matching the label on the vial.
• HPLC purity result, ideally with the chromatogram attached.
• Mass spectrometry result confirming the molecular weight.
• Appearance, solubility, and moisture or counter-ion content where relevant.
• Date of analysis and signature of the analyst or authorised person.

Red flags

• No batch number, or a batch number that does not match the vial.
• A chromatogram that is not attached or has no axis labels.
• Purity claims without a supporting method.
• Results that look identical across multiple batches — real batches vary slightly.

Peptides are chemically stable if they are stored correctly, and remarkably fragile if they are not. The two enemies are moisture and heat. A lyophilised peptide sealed in a dry, cold environment can remain usable for years. The same peptide left on a bench for a fortnight can degrade meaningfully.

Lyophilised peptides

Lyophilisation, or freeze-drying, removes water from a peptide preparation and leaves behind a dry powder or "cake". In this form the peptide is chemically quiet: without water, most of the reactions that degrade peptides simply cannot proceed. Lyophilised peptides are typically stored at -20°C, protected from light and moisture, and remain stable for many months to a few years depending on the sequence.

Reconstituted peptides

Once a peptide is reconstituted in aqueous solvent, the stability clock starts. Reconstituted peptides are usually stored at 2-8°C and used within a few weeks, though the exact window depends on the sequence and the solvent. Peptides containing methionine, cysteine, or tryptophan are more prone to oxidation. Peptides with asparagine or glutamine adjacent to glycine are more prone to deamidation.

Freeze-thaw cycles

Repeated freezing and thawing degrades peptides in solution. If a reconstituted peptide needs to be stored for longer than a couple of weeks, the best practice is to divide it into single-use aliquots before freezing so that each aliquot is thawed only once.

Storage rules of thumb

• Lyophilised long term: -20°C, sealed, desiccated, protected from light.
• Reconstituted short term: 2-8°C, sealed, used within a few weeks.
• Reconstituted long term: aliquot and store at -20°C or below.
• Always let vials warm to room temperature before opening to avoid condensation.

Reconstitution is the process of adding a solvent to a lyophilised peptide to bring it into solution. Done properly, it is straightforward. Done carelessly, it can degrade a perfectly good peptide before it has been used once.

Choosing a solvent

Bacteriostatic water — sterile water containing 0.9% benzyl alcohol as a preservative — is the standard solvent for most research peptides that are stable in aqueous solution. Some sequences require sterile water for injection instead, because benzyl alcohol can interact with sensitive residues. Occasionally a small percentage of acetic acid or DMSO is needed to dissolve hydrophobic peptides. The right choice is the one specified in the peptide's technical data sheet.

Technique

• Bring both vials to room temperature before opening.
• Wipe the stoppers with alcohol and let them dry.
• Draw the correct volume of solvent into a sterile syringe.
• Inject the solvent slowly down the inside of the vial wall, not straight onto the peptide cake.
• Do not shake. Swirl gently, or leave the vial upright for a few minutes, until the peptide has fully dissolved.
• Label the vial with the concentration and the date of reconstitution.

Calculating concentration

The peptide mass in the vial divided by the solvent volume added is the concentration. If a 5 mg vial is reconstituted with 2 mL of bacteriostatic water, the concentration is 2.5 mg/mL. From there, the volume corresponding to any desired dose is a simple ratio. A reconstitution calculator handles the arithmetic quickly, but every researcher should be able to do it on paper.

Are peptides drugs?

Some peptides are approved drugs, but most research peptides are not. A research peptide is a laboratory material for use in scientific investigation; it is not a medicine and it is not intended for human use.

What does "≥98% purity" mean?

It means that at least 98% of the total peptide content, as measured by HPLC, is the intended sequence. The remaining fraction is impurities from synthesis.

Why is HPLC the standard test?

HPLC separates the components of a mixture cleanly and quantitatively, and it is fast enough to be used on every batch. Coupled with mass spectrometry, it identifies both purity and identity in a single workflow.

How long do lyophilised peptides last?

Correctly stored at -20°C, sealed and desiccated, most lyophilised peptides remain stable for at least two years. Some are stable for considerably longer. Sequences with reactive residues age faster than robust ones.

How long do reconstituted peptides last?

A few weeks at 2-8°C is typical for a sealed, correctly reconstituted vial. Longer storage requires aliquoting and freezing.

Can I trust a certificate of analysis at face value?

Trust, but verify. A credible CoA is batch-specific, dated, signed, and includes the underlying chromatograms. Generic or unattributed documents should not be treated as evidence.

The following references are a starting point for readers who want to go deeper. They are drawn from peer-reviewed literature and standard reference texts.

1. Merrifield, R.B. (1963). Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. Journal of the American Chemical Society, 85(14), 2149–2154.
2. Chan, W.C. & White, P.D. (2000). Fmoc Solid Phase Peptide Synthesis: A Practical Approach. Oxford University Press.
3. Drucker, D.J. (2018). Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metabolism, 27(4), 740–756.
4. Fosgerau, K. & Hoffmann, T. (2015). Peptide therapeutics: current status and future directions. Drug Discovery Today, 20(1), 122–128.
5. Muttenthaler, M., King, G.F., Adams, D.J. & Alewood, P.F. (2021). Trends in peptide drug discovery. Nature Reviews Drug Discovery, 20, 309–325.
6. Manning, M.C., Chou, D.K., Murphy, B.M., Payne, R.W. & Katayama, D.S. (2010). Stability of protein pharmaceuticals: an update. Pharmaceutical Research, 27, 544–575.
7. Snyder, L.R., Kirkland, J.J. & Dolan, J.W. (2010). Introduction to Modern Liquid Chromatography, 3rd Edition. Wiley.